Monthly Archives: July 2018

Sure Ventures PLC – Final Results

LONDON, UK / ACCESSWIRE / July 31, 2018 / Sure Ventures plc (‘Sure Ventures’ or ‘the Company’)

Final Results

Sure Ventures plc (LSE: SURE) a venture capital fund which invests in early stage software companies in the rapidly growing financial technology (‘fintech’), augmented reality (‘AR’), virtual reality (‘VR’), and Internet of Things (‘IoT’) sectors, is pleased to announce its results for the period between 21 June 2017 to 31 March 2018. The Company’s annual report and audited financial statements will be posted to shareholders shortly and will be made available on the Company’s website www.sureventuresplc.com.

Overview

Listed in January 2018 having raised £3.3 million

Strategy to target capital growth by investing in early stage technology companies in the fintech, AR/VR and IoT sectors, with a focus on software-centric businesses

4.5 million commitment to Suir Valley Ventures Fund at a price of €100 cents – the last recorded dealing NAV as at March 2018 was recorded at €124 cents per share

Suir Valley Ventures Fund has five initial investments across target sectors including recently listed VR Education plc

Post period end, direct investment in Immotion Plc, which subsequently listed on AIM resulting with a current 114% uplift in the value of Sure Ventures holding

Chairman’s Statement

Sure Ventures listed in January this year having raised £3.3 million. The Company’s performance has been in line with expectations. By targeting fintech, AR, VR and IoT, the Company provides investors access to early stage opportunities in fast growing areas that the board believes will increasingly play key roles in our everyday lives.

Sure Ventures has made a €4.5 million commitment to Suir Valley Ventures Fund at a price of €100 cents. The last recorded dealing NAV as at March 2018 was recorded at €124 cents per share. This gain was largely down to the successful flotation and valuation uplift in VR Education plc (VRE.L), one of its portfolio companies that listed on AIM at 10p per share on 12 March 2018. The share price of VR Education at the close of business on 30 July 2018 was 18.6 pence per share. The Suir Valley Ventures Fund has now made five investments in the AR, VR, fintech and IoT sectors. The Company believes that investment opportunities in its chosen sectors will continue to strengthen.

Post period end, in April 2018 Sure Ventures invested £500,000 directly into Immotion Plc, a UK-based company focused on becoming a leading participant in the ‘Out of Home’ VR experience market by creating and publishing high quality VR content and combining it with its VR motion platforms to create truly immersive experiences. Immotion (IMMO) listed on AIM on 12 July 2018 at 10 pence per share. The share price of Immotion at the close of business on 30 July 2018 was 13.5 pence per share at which price Sure Ventures’ holding in Immotion was valued at circa £ 1.1 million

On 2 July 2018 Sure Ventures announced the issue of £200,000 of new ordinary shares.

We are pleased with the progress made by the Company to date following its listing in January 2018 and with the performance of the investments made by Sure Ventures and Suir Valley Ventures Fund, both of which are managed by Shard Capital AIFM LLP. We believe that Sure Ventures offers investors an exciting opportunity to gain exposure to early stage companies in our target sectors: fintech, AR, VR and IoT. We look forward to updating the market and our shareholders on our investment performance and progress on an ongoing basis.

Finally, I would like to thank all the team for their hard work and shareholders for their support. I look forward to communicating regularly as our current investee companies build their businesses and we identify further investment opportunities.

Sean Nicolson

Chairman

31 July 2018

Statement of Comprehensive Income

For the period from 21 June 2017 (date of incorporation) to 31 March 2018

Notes

Revenue

£

Capital

£

Total

£

Income

Other net changes in fair value on financial assets at fair value through profit or loss

4

44,980

44,980

Total net income

44,980

44,980

Expenses

Management fee

5

(1,155)

(3,611)

(4,766)

Custodian, secretarial and administration fees

(19,850)

(19,850)

Other expenses

6

(230,282)

(230,282)

Total operating expenses

(251,287)

(3,611)

(254,898)

(Loss) / Profit before Taxation and after finance costs

(251,287)

41,369

(209,918)

Taxation

7

(Loss) / Profit after taxation

(251,287)

41,369

(209,918)

Earnings per share

8

(7.59)
p

1.25
p

(6.34)
p

The total column of this statement represents the Statement of comprehensive income prepared in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the European Union. The supplementary revenue return and capital return columns are both prepared under guidance issued by the Association of Investment Companies. All items in the above statement derive from continuing operations.

No operations were acquired or discontinued during the period.

The Company does not have any income or expense that is not included in net profit for the period. Accordingly, the net profit for the period is also the Total Comprehensive Income for the period, as defined in IAS1 (revised).

Statement of Financial Position

As at 31 March 2018

Notes

31 March 2018

£

Non-current assets

Investments held at fair value through profit or loss

9

739,258

739,258

Current assets

Receivables

10

689,713

Cash and cash equivalents

1,663,505

2,353,218

Total assets

3,092,476

Current liabilities

Management fee payable

11

(4,766)

Other payables

11

(38,550)

(43,316)

Total assets less current liabilities

3,049,160

Total net assets

3,049,160

Shareholders’ funds

Ordinary share capital

12

33,100

Share premium

12

3,225,978

Revenue reserves

(251,287)

Capital reserves

41,369

Total shareholders’ funds

3,049,160

Net asset value per share

13

92.12
p

Statement of Changes in Equity

For the period from 21 June 2017 (date of incorporation) to 31 March 2018

Ordinary

Share

Capital

£

Share

Premium

£

Revenue

Reserves

£

Capital

Reserves

£

Total

Reserves

£

Total

Equity

£

Balance at 21 June 2017

Ordinary shares issued

33,100

3,276,900

3,310,000

Ordinary shares issue costs

(50,922)

(50,922)

(Loss) / Profit after taxation

(251,287)

41,369

(209,918)

(209,918)

Dividends paid in the period

Balance at 31 March 2018

33,100

3,225,978

(251,287)

41,369

(209,918)

3,049,160

As at 31 March 2018 the Company had distributable reserves of £nil for the payment of future dividends. The distributable reserves are the revenue reserves £nil, realised capital reserves (£nil) and the special distributable reserves (£nil).

Statement of Cash Flows

For the period from 21 June 2017 (date of incorporation) to 31 March 2018

Notes

31 March 2018

£

Cash flows from operating activities:

(Loss) after taxation

(209,918)

Adjustments for:

Increase in payables

11

43,316

Unrealised (loss) on foreign exchange

9

6,875

Net changes in fair value on financial assets at fair value through profit or loss

9

(51,855)

Net cash inflow from operating activities

(211,582)

Cash flows from investing activities:

Purchase of investments

9

(694,278)

Net cash (outflow) from investing activities

(694,278)

Cash flows from financing activities:

Proceeds from issue of ordinary shares

2,620,287

Share issue costs

(50,922)

Net cash inflow from financing activities

2,569,365

Net change in cash and cash equivalents

1,663,505

Cash and cash equivalents at the beginning of the period

Net cash and cash equivalents

1,663,505

Notes to the Financial Statements

1) PRINCIPAL ACCOUNTING POLICIES

Basis of accounting

The financial statements of Sure Ventures plc (the “Company”) have been prepared in accordance with International Financial Reporting Standards (IFRS) and IFRIC interpretations (IFRS IC) as adopted by the European Union and the Companies Act 2006 applicable to companies reporting under IFRS.

The principal accounting policies adopted by the Company are set out below. Where presentational guidance set out in the Statement of Recommended Practice (‘SORP’) for investment trusts issued by the Association of Investment Companies (‘AIC’) in January 2017 is consistent with the requirements of IFRS, the directors have sought to prepare the financial statements on a basis compliant with the recommendations of the SORP.

All values are rounded to the nearest pound unless otherwise indicated.

Foreign Currency

The presentation currency of the Company is pounds sterling, the financial statements are prepared in this currency in accordance with the Company’s prospectus. The Company is required to nominate a functional currency, being the currency in which the Company predominantly operates. The board has determined that determined that sterling is the Company’s functional currency.

Transactions involving foreign currencies would be converted at the exchange rate ruling at the date of the transaction. Foreign currency monetary assets and liabilities would be translated into pounds sterling at the exchange rate ruling on the year-end date. Foreign exchange differences arising on translation would be recognised in the Statement of Comprehensive Income.

Foreign exchange gains and losses relating to the financial assets and liabilities carried at fair value through profit or loss are presented in the statement of comprehensive income within ‘other net changes in fair value on financial assets and financial liabilities at fair value through profit or loss’.

Presentation of Statement of comprehensive income

In order to better to reflect the activities of an investment trust company and in accordance with guidance issued by the AIC, supplementary information which analyses the Statement of comprehensive income between items of a revenue and capital nature has been presented alongside the Statement of comprehensive income.

Income

Dividend income from investments is recognised when the Company’s right to receive payment has been established, normally the ex-dividend date.

Interest income in profit or loss in the Statement of Comprehensive Income includes bank interest. Interest income is recognised on an accruals basis.

Capital income, all changes in fair value are recognised in profit or loss in the Statement of Comprehensive Income as net gain on investment at fair value through profit or loss.

Expenses

All expenses are accounted for on the accruals basis. In respect of the analysis between revenue and capital items presented within the Statement of Comprehensive Income, all expenses have been presented as revenue items except as follows:

· Transaction costs which are incurred on the purchases or sales of investments designated as fair value through profit or loss are expensed to capital in the Statement of comprehensive income.

· Expenses are split and presented partly as capital items where a connection with the maintenance or enhancement of the value of the investments held can be demonstrated and, accordingly, the management fee for the financial period has been allocated 24.24% to revenue and 75.76% to capital (Investment held at fair value through profit or loss to the net asset value of the Company), in order to reflect the directors’ long term view of the nature of the expected investment returns of the Company.

Capital Reserves Unrealised

Increases and decreases in the valuation of investments and realised/unrealised foreign exchange gain/(loss) held at the year-end are accounted for in the capital reserves unrealised.

Taxation

In line with the recommendations of the SORP, the allocation method used to calculate tax relief on expenses presented against capital returns in the supplementary information in the Statement of comprehensive income is the ‘marginal basis’. Under this basis, if taxable income is capable of being entirely offset by expenses in the revenue column of the statement of comprehensive income, then no tax relief is transferred to the capital return column.

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit and is accounted for using the Statement of Financial Position liability method. Deferred tax liabilities are recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised.

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the revenue return column of the Statement of comprehensive income, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.

Investment trusts which have approval under Part 24, Chapter 4 of the Corporation Tax Act 2010 are not liable for taxation on capital gains.

Financial instruments

Financial assets and financial liabilities are recognised in the Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument. The Company shall offset financial assets and financial liabilities if it has a legally enforceable right to set off the recognised amounts and interests and intends to settle on a net basis. Financial assets and liabilities are derecognised when the Company settles its obligations relating to the instrument.

Classification

Under IAS 39 the Company can classify its financial assets into the following measurement categories: (i) financial assets held at fair value through profit or loss (“FVPL”); (ii) loans and receivables; and (iii) available for sale. Financial liabilities can be classified as either held at fair value through profit or loss, or at amortised cost using the effective interest rate method.

Financial assets and liabilities are classified at initial recognition.

Financial assets and liabilities held at fair value through profit or loss.

A financial asset or liability is classified as trading if acquired principally for the purpose of selling in the short-term, this does not apply to the Company.

Financial assets and liabilities may be designated at fair value through profit or loss when:

the designation eliminates or significantly reduces a measurement or recognition inconsistency that would otherwise arise from measuring assets or liabilities on a different basis;

a group of financial assets and/or liabilities is managed and its performance evaluated on a fair value basis; or

the assets or liabilities include embedded derivatives and such derivatives are required to be recognised separately.

Financial assets and liabilities held at fair value through profit or loss are subsequently carried at fair value, with gains and losses arising from changes in fair value taken directly to the income statement.

Loans and receivables

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market and it is expected that substantially all of the initial investment will be recovered, other than because of credit deterioration. Loans and receivables are subsequently carried at amortised cost using the effective interest method and recorded net of provisions for impairment losses.

Derecognition

Financial assets are derecognised when the rights to receive cash flows from the financial assets have expired or where the group has transferred substantially all risks and rewards of ownership. If substantially all the risks and rewards have been neither retained nor transferred and the group has retained control, the assets continue to be recognised to the extent of the group’s continuing involvement. Financial liabilities are derecognised when they are extinguished.

Investments

All investments held by the Company have been designated at fair value through profit or loss (‘FVPL’) but are also described in these financial statements as investments held at fair value, and are valued in accordance with the International Private Equity and Venture Capital Valuation Guidelines (‘IPEVCV’) effective 1 January 2016 as recommended by the British Private Equity and Venture Capital Association.

Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional.

Receivables

Receivables do not carry any interest and are short term in nature. They are initially stated at their nominal value and reduced by appropriate allowances for estimated irrecoverable amounts (if any).

Cash and cash equivalents

Cash and cash equivalents (which are presented as a single class of asset on the Statement of Financial Position) comprise cash at bank and in hand and deposits with an original maturity of three months or less. The carrying value of these assets approximates their fair value.

Payables

Payables are non-interest bearing.

Dividends

Interim dividends are recognised in the year in which they are paid. Final dividends are recognised when they have been approved by shareholders.

Adoption of New and Revised Standards

The International Accounting Standards Board has issued the following standards, which are relevant to the Company’s reporting but which have not yet been applied and have an effective date after the date of these financial statements:

IFRS 9 Financial Instruments

IFRS 9 “Financial Instruments”, brings together the classification and measurement, impairment and hedge accounting phases of the International Accounting Standards Board’s (“IASB”) project to replace IAS 39, and is effective for annual periods beginning on or after 1 January 2018. The key elements of the standard are as follows:

Classification and measurement – IFRS 9 applies one classification approach for all types of financial assets. Two criteria are used to determine how financial assets should be classified and measured: (a) the entity’s business model (i.e. how an entity manages its financial assets in order to generate cash flows by collecting contractual cash flows, selling financial assets or both); and (b) the contractual cash flow characteristics of the financial asset (i.e. whether the contractual cash flows are solely payments of principal and interest).

Impairment – the incurred loss model under IAS 39 is replaced with a new expected loss model. Impairment provisions are driven by changes in credit risk of instruments, with a provision for lifetime expected credit losses recognised where the risk of default of an instrument has increased significantly since initial recognition. Risk of default and expected credit losses must incorporate forward-looking and macroeconomic information. Expected credit loss models will require more data and assumptions with impairment provisions potentially becoming more volatile.

Hedge accounting – the new requirements align hedge accounting more closely with risk management. The revised standard also establishes a more principles-based approach to hedge accounting.

The Company is currently working on its ability to:

review the classification and measurement of financial instruments under the requirements of IFRS 9;

develop and validate a set of IFRS 9 models for calculating expected credit losses on the Company’s loan portfolios; and

implement internal governance processes which are appropriate for IFRS 9.

The directors do not anticipate that the adoption of this standard and interpretations will have a material impact on the financial statements in the period of initial application.

IFRS 15 Revenue from Contracts with Customers

The directors do not anticipate that the adoption of this standard and interpretations will have a material impact on the financial statements in the period of initial application.

IFRS 16 Leases

The directors do not anticipate that the adoption of this standard and interpretations will have a material impact on the financial statements in the period of initial application.

Other future developments include the International Accounting Standards Board (‘IASB’) undertaking a comprehensive review of existing IFRSs. The Company will consider the financial impact of these new standards as they are finalised.

New Standards, Amendments and Interpretations

Standards, amendments and interpretations to existing standards that become effective in future accounting periods and have not been adopted by the Company are as follows:

IFRS Effective for annual periods beginning on or after

IFRS 9 – Financial Instruments 1 January 2018

IFRS 15 – Revenue from Contracts with Customers 1 January 2018

IFRS 16 – Leases 1 January 2019

The directors do not anticipate that the adoption of these standards and interpretations will have a material impact on the financial statements in the period of initial application.

CAPITAL STRUCTURE

Share Capital

Ordinary shares are classed as equity. The ordinary shares in issue have a nominal value of one penny and carry one vote each.

Share Premium

This reserve represents the difference between the issue price of shares and the nominal value of shares at the date of issue, net of related issue costs.

Capital Reserve Unrealised

Unrealised gains and losses on investments held at the year end arising from movements in fair value are taken to the capital reserve.

Revenue Reserve

Net revenue profits and losses of the Company.

2) SIGNIFICANT ACCOUNTING JUDGEMENTS, ESTIMATES AND ASSUMPTIONS

The preparation of financial statements in conformity with IFRS as adopted in the EU requires the Company to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Although these estimates are based on the directors’ best knowledge of the amount, actual results may differ ultimately from those estimates.

The areas requiring a higher degree of judgement or complexity and areas where assumptions and estimates are significant to the financial statements are in relation to investments at fair value through profit or loss described below.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected.

Equity Investments

The unquoted equity assets are valued on periodic basis using techniques including a market approach, costs approach and/or income approach. The valuation process is collaborative, involving the finance and investment functions within the manager with the final valuations being reviewed by the manager’s valuation committee.

Shareholders should note that increases or decreases in any of the inputs in isolation may result in higher or lower fair value measurements. Changes in fair value of all investments held at fair value are recognised in the Statement of comprehensive income as a capital item. On disposal, realised gains and losses are also recognised in the Statement of comprehensive income.

3) SEGMENTAL REPORTING

The Company’s board and the Investment Manager consider investment activity in selected Equity Assets as the single operating segment of the Company, being the sole purpose for its existence. No other activities are performed.

The directors are of the opinion that the Company is engaged in a single segment of business and operations of the Company are wholly in the United Kingdom.

4) INCOME

From the date of incorporation to 31 March

2018

£

Investment income

Investments at fair value through profit or loss

51,855

Total investment income

51,855

Unrealised (loss) on translation of investments

(6,875)

Total income

44,980

5) MANAGEMENT AND PERFORMANCE FEE

Management Fee

The management fee is payable quarterly in advance at a rate equal to 1/4 of 1.25% per month of net asset value (the ”Management Fee”). The aggregate fee payable on this basis must not exceed 1.25% of the net assets of the Company in any year.

From the period from first admission, the management fee payable was based on 1.25% of the net asset value.

Performance Fee

The Manager is entitled to a performance fee, which is calculated in respect of each twelve month period starting on 1 April and ending on 31 March in each calendar year (‘Calculation Period’), and the final Calculation Period shall end on the day on which the management agreement is terminated or, if earlier, the business day immediately preceding the day on which the Company goes into liquidation.

The Manager is entitled to receive a performance fee equal to 15% of any excess returns over a high watermark, subject to achieving a hurdle rate of 8% in respect of each performance period. There was no performance fee payable during the period.

6) OTHER EXPENSES

From the date of incorporation to 31 March
2018
£

Auditor’s remuneration – audit fees

20,000

Directors’ fees

21,509

Organisation expense

150,801

VAT Expense

27,821

Legal and other professional

8,984

Other expenses

1,167

Total Other expenses

230,282


All expenses are inclusive of VAT where applicable.

7) TAXATION

As an investment trust the Company is exempt from corporation tax on capital gains. The Company’s revenue income is subject to tax, but offset by any interest distribution paid, which has the effect of reducing that corporation tax to nil. This means the interest distribution may be taxable in the hands of the Company’s shareholders.

Any change in the Company’s tax status or in taxation legislation generally could affect the value of investments held by the Company, affect the Company’s ability to provide returns to shareholders, lead the Company to lose its exemption from UK Corporation tax on chargeable gains or alter the post-tax returns to shareholders. It is not possible to guarantee that the Company will remain a non-close company, which is a requirement to maintain status as an investment trust, as the ordinary shares are freely transferable. The Company, in the event that it becomes aware that it is a close company, or otherwise fails to meet the criteria for maintaining investment trust status, will as soon as reasonably practicable, notify shareholders of this fact.

The Company is in the process of obtaining this approval from HM Revenue & Customs

The following table presents the tax chargeable on the Company for the period ended 31 March 2018.

Revenue
£

Capital
£

Total
£

Corporation tax

Total current tax charge

Deferred tax movement

Deferred tax movement PYA

Total tax charge in income statement

Factors affecting taxation charge for the year

The taxation charge for the year is lower than the standard rate of UK corporation tax of 19.00%. A reconciliation of the taxation charge based on the standard rate of UK corporation tax to the actual taxation charge is shown below.

Revenue
£

Capital
£

Total
£

Return on ordinary activities before taxation

(251,287)

41,369

(209,919)

Return on ordinary activities before taxation multiplied by the standard rate of UK corporation tax of 19%

(47,745)

7,860

(39,885)

Effects of:

Excess management expenses not utilised

47,745

(7,860)

(39,885)

Interest distributions paid in respect of the period

Total tax charge in income statement

Overseas taxation

The Company may be subject to taxation under the tax rules of the jurisdictions in which it invests, including by way of withholding of tax from interest and other income receipts. Although the Company will endeavour to minimise any such taxes this may affect the level of returns to shareholders.

8) EARNINGS PER SHARE

For the financial period ended 31 from March 2018

Revenue
pence

Capital
pence

Total
pence

Earnings per ordinary share

(7,59)p

1.25p

(6.34)p


The calculation of the above is based on revenue returns of (£251,287), capital returns of £41,369 and total returns of (£209,919) and number of ordinary shares of 3,310,000 as at 31 March 2018.

9) INVESTMENTS AT FAIR VALUE THROUGH PROFIT OR LOSS

(a) Movements in the year

As of 31 March 2018
£

Opening cost

Opening fair value

Purchases at cost

694,278

Cost at fair value measurement

51,855

Unrealised (loss) on foreign exchange

(6,875)

Closing fair value at 31 March 2018

739,258

(b) Fair value of financial instruments

IFRS 13 requires the Company to classify its financial instruments held at fair value using a hierarchy that reflects the significance of the inputs used in the valuation methodologies. These are as follows:

· Level 1 – quoted prices in active markets for identical investments;

· Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayments, credit risk, etc.); and

· Level 3 – significant unobservable inputs (including the Company’s own assumptions in determining the fair value of investments).

The following sets out the classifications used as at 31 March 2018 in valuing the Company’s investments:

Level 1
£

Level 2
£

Level 3
£

Total
£

Unquoted equity assets

739,258

739,258

Closing fair value as at 31 March 2018

739,258

739,258

Suir Valley Ventures (the “Fund”)

The fair value of the investment is determined with reference to audited NAV (Net asset value) of the Fund at each reporting date. The Fund invests in a mixture of quoted and unquoted investments. All investments at the Fund level are measured at fair value.

10) RECEIVABLES

31 March 2018
£

Prepayments

Other receivables

689,713

Total receivables

689,713

The above receivables relate to the proceeds from the issue of ordinary shares which were recovered partially in April 2018 and the remainder in June 2018 following the period end.

The above receivables do not carry any interest and are short term in nature. The directors consider that the carrying values of these receivables approximate their fair value.

11) OTHER PAYABLES

31 March 2018
£

Management fee payable

4,766

Accruals and deferred income

38,550

Total other payables

43,316


The above payables do not carry any interest and are short term in nature. The directors consider that the carrying values of these payables approximate their fair value.

12) ORDINARY SHARE CAPITAL

The table below details the issued share capital of the Company as at the date of the Financial Statements.

Issued and allotted

No. of shares
31 March 2018


£

Ordinary shares of 1 penny each

3,310,000

33,100


On incorporation, the issued share capital of the Company was £0.01 represented by one ordinary share of £0.01. Redeemable preference shares of 50,000 were also issued with a nominal value of £1 each, of which 25% was paid. The redeemable shares were issued to enable the Company to obtain a certificate of entitlement to conduct business and to borrow under section 761 of the Companies Act 2006. The redeemable shares were redeemed on listing from the proceeds of the issue of the new ordinary shares upon admission on 19 January 2018.

3,310,100 ordinary shares of £0.01 each were issued to shareholders as part of the placing and offer for subscription in accordance with the Company’s prospectus dated 17 November 2017 and the supplementary prospectus dated 2 January 2018. £689,713 of proceeds from this issue remained receivable at the period end and were collected in full after the period end.

13) NET ASSET VALUE PER ORDINARY SHARE

Year ended 31 March 2018

Net asset
value per
ordinary share
Pence

Net assets
attributable
£

Ordinary shares of 1 penny each

92.12p

3,049,160


The net asset value per ordinary share is based on net assets at the period end of £3,049,160 and on 3,310,000 ordinary shares in issue at the period end.

14) CONTINGENT LIABILITIES AND CAPITAL COMMITMENTS

The Company may invest in Suir Valley Ventures or other collective investment vehicles, subscriptions to which are made on a commitment basis. The Company will be expected to make a commitment that may be drawn down, or called, from time to time at the discretion of the manager of the Fund or other collective investment vehicle. The Company will usually be contractually obliged to make such capital call payments and a failure to do so would usually result in the Company being treated as a defaulting investor by the Fund or other collective investment vehicle.

The Company will seek to satisfy capital calls on its commitments through a combination of reserves, and where applicable the realisation, of Cash and Cash Equivalents and Liquid Investments (as each expression is defined in the prospectus dated 17 November 2017), anticipated future cash flows to the Company, the use of borrowings and, potentially, further issues of Shares.

As of 31 March 2018, the Company had outstanding commitments in relation to the Fund in the amount of €3,8 million.

15) RELATED PARTY TRANSACTIONS AND TRANSACTIONS WITH THE MANAGER

Directors – The remuneration of the directors is set out in the directors’ Remuneration Report on page 32. There were no contracts subsisting during or at the end of the period in which a director of the Company is or was interested and which are or were significant in relation to the Company’s business. There were no other transactions during the period with the directors of the Company. The directors do not hold any ordinary shares of the Company.

At 31 March 2018, there was £203 payable to the directors for fees and expenses.

Manager – Shard Capital AIFM LLP (the ‘Manager’), a UK-based company authorised and regulated by the Financial Conduct Authority, has been appointed the Company’s manager and authorised investment fund manager for the purposes of the Alternative Investment Fund Managers Directive. Details of the services provided by the manager and the fees paid are given in Note 5.

During the period the Company incurred £4,767 of fees and at 31 March 2018, there was £4,767 payable to the manager.

During the period the Company paid £50,922 of placement fees to Shard Capital Partners LLP.

During the period the manager paid £12,000 of to the advisor in relation to the flotation.

16) FINANCIAL RISK MANAGEMENT

The Company’s investment objective is to achieve capital growth for investors pursuant to the investment policy outlined in the prospectus, this involves certain inherent risks. The main financial risks arising from the Company’s financial instruments are market risk, credit risk and liquidity risk. The board reviews and agrees policies for managing each of these risks as summarised below.

Market risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate. Market risk comprises three types of risk, price risk, interest rate risk and currency risk.

· Price risk – the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk);

· Interest rate risk – the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in market interest rates; and

· Currency risk – the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in foreign exchange rates.

The Company’s exposure, sensitivity to and management of each of these risks is described below. Management of market risk is fundamental to the Company’s investment objective. The investment portfolio is continually monitored to ensure an appropriate balance of risk and reward within the parameters of the investment restrictions outlined in the prospectus.

(a) Price risk

Price risk arises mainly from uncertainty about future prices of financial instruments used in the Company’s business. It represents the potential loss the Company might suffer through holding market positions in the face of price movements (other than those arising from interest rate risk or currency risk) specifically in equity investments purchased in pursuit of the Company’s investment objective, held at fair value through the profit and loss.

As at 31 March 2018 the Company held one direct private equity investment in the participating shares of Suir Valley Ventures, a sub-fund of Suir Valley Funds ICAV.

As at 31 March 2018 the investment in Suir Valley Ventures is valued at the net asset value of the sub-fund, as calculated by its administrator.

At 31 March 2018, had the fair value of investments strengthened by 10% with all other variables held constant, net assets attributable to holders of participating shares would have increased by £73,925. A 10% weakening of the market value of investments against the above would have resulted in an equal but opposite effect on the above financial statement amounts to the amounts shown above, on the basis that all other variables remain constant. Actual trading results may differ from this sensitivity analysis and the difference may be material.

(b) Interest rate risk

Interest rate risk arises from the possibility that changes in interest rates will affect future cash flows or the fair values of financial instruments.

The Company’s currently employs no borrowings.

The Company finances its operations mainly through its share capital and reserves, including realised gains on investments.

Exposure of the Company’s financial assets and liabilities to floating interest rates (giving cash flow interest rate risk when rates are reset) and fixed interest rates (giving fair value risk) as at 31 March 2018 is shown below:

Financial instrument

Floating Rate
£

Fixed or
Administered Rate
£

Total
£

Cash and cash equivalents

1,663,505

1,663,505

Total exposure

1,663,505

1,663,505


An administered rate is not like a floating rate, movements in which are directly linked to LIBOR. The administered rate can be changed at the discretion of the lender.

(c) Currency risk

As at 31st March 2018 the Company’s sole investment is denominated in euros whereas its functional and presentation currency is pounds sterling. Consequently, the Company is exposed to risks that the exchange rate of its currency relative to euros may change in a manner that has an adverse effect on the fair value of the Company’s assets.

At the reporting date the carrying value of the Company’s financial assets and liabilities held in individual foreign currencies as a percentage of its net assets were as follows:

Foreign currency exposure as a percentage of net assets

31 March 2018

Euros

24%

Sensitivity analysis

If the euro exchange rates increased/decreased by 10% against pounds sterling, with all other variables held constant, the increase/decrease in the net asset attributable to the Company arising from a change financial assets at fair value through profit or loss, which are denominated in euros, would have been +/- £73,925.

17) CREDIT RISK

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation.

The Company’s credit risks arise principally through cash deposited with banks, which is subject to risk of bank default.

The Company ensures that it only makes deposits with institutions with appropriate financial standing.

Liquidity Risk

Liquidity risk is the risk that the company will have difficulty in meeting its obligations in respect of financial liabilities as they fall due.

The Company manages its liquid resources to ensure sufficient cash is available to meet its expected contractual commitments. It monitors the level of short-term funding and balances the need for access to short-term funding, with the long-term funding needs of the Company.

Capital Management

The Company’s capital is represented by ordinary shares and reserves.

The Company’s primary objectives in relation to the management of capital are:

· to maximise the long-term capital growth for its shareholders pursuant to its investment objective;

· to ensure its ability to continue as a going concern.

The Company manages its capital structure and liquidity resources to meet its obligations as described above.

Borrowing limits

Pursuant to the prospectus dated 17 November 2017 the Company can deploy gearing up to 20% of the net asset value of the Company (calculated at the time of borrowing) to seek to enhance returns and for the purpose of capital flexibility and efficient portfolio management. During the period ended 31st March 2018 the Company employed no gearing.

18) ULTIMATE CONTROLLING PARTY

It is the opinion of the directors that there is no ultimate controlling party.

19) Subsequent Events

£689,713 disclosed as receivable in the Statement of Position were recovered in full post year end.

On 24 April 2018 the Company completed a direct investment in Immotion Group Limited totalling £500,254.

On 29 June 2018 the Company raised gross proceeds of £200,000 by issuing ordinary shares at £1.00 each. The shares were admitted to the Specialist Funds Segment of the Main Market of the London Stock Exchange and dealings in these ordinary shares commenced on 5 July 2018. The Company now has 3,510,000 ordinary shares in issue following this recent admission.

For further information, please visit www.sureventuresplc.com or contact:

Gareth Burchell

Sure Ventures plc

+44 (0) 20 7186 9918

Isabel de Salis / Priit Piip

St Brides Partners (Financial PR)

+44 (0) 20 7236 1177

Notes to Editors

Sure Ventures plc listed on the London Stock Exchange in January 2018, giving retail investors access to an asset class that is usually dominated by private venture capital funds. The Company aims to provide investors with a diversified exposure to three rapidly-growing markets: augmented reality/virtual reality, FinTech and Internet of Things. Sure Ventures is focusing on companies in the UK, Republic of Ireland and other European countries, making seed and series A investments in companies with first rate management teams, products which benefit from market validation with target revenue run rates of at least £400,000 over the next 12 months. Website: https://www.sureventuresplc.com/.

SOURCE: Sure Ventures plc

ReleaseID: 507453

Evotec Repays 50% Of EUR 140 M Acquisition Loan

STRONG OPERATIONAL CASHFLOW FACILITATES REPAYMENT OF EUR 70 M WITHIN THE FIRST YEAR OF THE LOAN TERM
EUR 140 M LOAN WAS TAKEN TO EXPAND EVOTEC’S VALUE CHAIN WITH APTUIT IN AUGUST 2017

HAMBURG, GERMANY / ACCESSWIRE / July 31, 2018 / Evotec AG (FSE: EVT), (XETRA: EVT) (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that it completes the repayment of 50% of the EUR 140 m debt bridge facility within the first year of being granted in context of the Aptuit acquisition in 2017. Effective August 2017, Evotec acquired Aptuit, a partner research organisation for integrated outsourced drug discovery and development, for EUR 253.2 m in cash. This acquisition was financed through existing cash reserves and a new EUR 140 m senior debt bridge facility.

The repayment of EUR 70 m within the first year of the loan period is enabled mainly through the strong cash inflow from Evotec’s operational activities in the first half of 2018. In addition, Evotec refinanced part of the loan at highly attractive terms. Evotec expects the repayment to show a significantly positive effect on the net debt ratio in the Company’s results.

Enno Spillner, Chief Financial Officer of Evotec, commented: “This early repayment underlines our strong cash-generating operating business, despite full commitments to our long-term EVT Innovate R&D and capacity-building strategy.”

ABOUT EVOTEC AG

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic to meet the industry’s need for innovation and efficiency in drug discovery (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, infectious diseases, diabetes and complications of diabetes, pain, inflammation, and oncology and. On this basis, Evotec has built a broad and deep pipeline of more than 80 partnered product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term discovery alliances with partners including Bayer, CHDI, Sanofi and UCB and development partnerships with e.g. Sanofi in the field of diabetes, Pfizer in the field of tissue fibrosis and Celgene in the field of neurodegenerative diseases. For additional information, please go to www.evotec.com and follow us on Twitter @EvotecAG.

FORWARD LOOKING STATEMENTS

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.

Contact Evotec AG:

Gabriele Hansen, VP Corporate Communications & Investor Relations, Phone: +49.(0)40.56081-255, gabriele.hansen@evotec.com

SOURCE: Evotec AG

ReleaseID: 507489

Global specialty paper market is expected to flourish at a significant CAGR of 7.2% during the forecast period

Global specialty paper market is expected to flourish at a significant CAGR of 7.2% during the forecast period. Moreover, the global specialty paper market is expected to reach 34,954.3 KT by the end of 2021.

New York, United States – July 31, 2018 /MarketersMedia/

The global specialty paper market is segmented into product type such as release & labels, pharmaceutical leaflet papers, decor papers, flexible packaging paper and others. Among these segments, flexible packaging paper segment is expected to occupy top position in overall specialty paper market during the forecast period. Growing consumption of flexible packaging paper in food & beverages, healthcare and other products is driving the growth of the market. Moreover, factors such as less utilization of raw material, low weight and low shipping charges are anticipated to swell the growth of flexible packaging paper market.
Global specialty paper market is expected to flourish at a significant CAGR of 7.2% during the forecast period. Moreover, the global specialty paper market is expected to reach 34,954.3 KT by the end of 2021. Wide scale application of specialty paper in various industries is fostering the growth of specialty paper market. Moreover, advances in packaging industry are further anticipated to fuel the demand for specialty paper market.Asia Pacific showcased the highest demand for specialty paper in 2016. Further, riding on the back of factors such as rapid growth of food and beverage industry and growing utilization of masking tape in real estate, Asia-Pacific is projected to continue its dominance during the forecast period. Further, in developing nations such as China and India, innovations and technologies are driving packaging industry market. Moreover, packaging market is witnessing double digit growth in growing economies which further, is anticipated to positively impact the growth of the specialty paper market. Europe is the second biggest market and expected to showcase a tremendous growth over the forecast period i.e. 2017-2024.

Request For Free Sample Pages: https://www.researchnester.com/sample-request/2/rep-id-104

Rising Demand for Food & Beverage Products in the World

Increasing demand and consumption of food and beverages such as tea bags and bakery products is driving the growth of specialty paper market across the globe. Apart from this, rising disposable income and changing lifestyle of the people is anticipated to bolster the growth of the specialty paper market.

Technological Advancements and Developments

Advances in technologies such as thin elastic packaging materials are anticipated to drive the growth of the specialty paper market. Moreover, enhancements and developments in specialty paper such as gas barrier technologies are accelerating the growth of the global specialty paper market.Although, availability of alternatives such as glassine paper and growing trend of utilization of plastic wraps are some of the key factor which is likely to dampen the growth of specialty paper market during the forecast period.

Request For TOC Pages: https://www.researchnester.com/toc-request/1/rep-id-104

The report titled “Global Specialty Paper Market Analysis & Opportunity Outlook 2021” delivers detailed overview of the global specialty paper market in terms of market segmentation by product type, by raw material, by end user and by region.Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.This report also provides the existing competitive scenario of some of the key players of the global specialty paper market which includes company profiling of Mondi Plc., Oji Holdings, Nippon Paper Group, Stora Enso, Sappi Ltd., International Papers, Domtar Corporation, Asia Pulp and Paper Co. Ltd., Staples Inc. and Dunn Paper. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global specialty paper market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Request For Buy Now: https://www.researchnester.com/payment/rep-id-104

About Us:-

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Follow Us On Linkedin@https://www.linkedin.com/company/research-nester-pvt.-ltd./

Contact Info:
Name: Ajay Daniel
Organization: Research Nester Pvt. Ltd
Phone: +1 6465869123

Source URL: https://marketersmedia.com/global-specialty-paper-market-is-expected-to-flourish-at-a-significant-cagr-of-7-2-during-the-forecast-period/386588

For more information, please visit https://www.researchnester.com/reports/global-specialty-paper-market-analysis-opportunity-outlook-2021/104

Source: MarketersMedia

Release ID: 386588

Global Men Face Cleanser Market: Industry Size, Growth, Analysis and Forecast of 2025

New Study on “2018-2025 Men Face Cleanser Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Pune, India – July 31, 2018 /MarketersMedia/

Global Men Face Cleanser Industry

New Study on “2018-2025 Men Face Cleanser Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Men Face Cleanser market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Loreal
P&G
Unilever
Estee Lauder
KAO
Shiseido
Avon
LVMH
Chanel
Amore Pacific
Jahwa
Beiersdorf
Coty
Jialan
Inoherb
Sisley
Revlon
Jane Iredale
Henkel

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3080949-global-men-face-cleanser-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Men Face Cleanser in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Soap-Based Cleansing
Amino Acid Cleansing
Surfactant Cleansing
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Specialist Retailers
Factory Outlets
Internet Sales
Other

Some points from table of content:

Global Men Face Cleanser Market Research Report 2018
1 Men Face Cleanser Market Overview
1.1 Product Overview and Scope of Men Face Cleanser
1.2 Men Face Cleanser Segment by Type (Product Category)
1.2.1 Global Men Face Cleanser Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Men Face Cleanser Production Market Share by Type (Product Category) in 2017
1.2.3 Soap-Based Cleansing
1.2.4 Amino Acid Cleansing
1.2.5 Surfactant Cleansing
1.2.6 Other
1.3 Global Men Face Cleanser Segment by Application
1.3.1 Men Face Cleanser Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Specialist Retailers
1.3.3 Factory Outlets
1.3.4 Internet Sales
1.3.5 Other
1.4 Global Men Face Cleanser Market by Region (2013-2025)
1.4.1 Global Men Face Cleanser Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Men Face Cleanser (2013-2025)
1.5.1 Global Men Face Cleanser Revenue Status and Outlook (2013-2025)
1.5.2 Global Men Face Cleanser Capacity, Production Status and Outlook (2013-2025)

2 Global Men Face Cleanser Market Competition by Manufacturers
2.1 Global Men Face Cleanser Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Men Face Cleanser Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Men Face Cleanser Production and Share by Manufacturers (2013-2018)
2.2 Global Men Face Cleanser Revenue and Share by Manufacturers (2013-2018)
2.3 Global Men Face Cleanser Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Men Face Cleanser Manufacturing Base Distribution, Sales Area and Product Type
2.5 Men Face Cleanser Market Competitive Situation and Trends
2.5.1 Men Face Cleanser Market Concentration Rate
2.5.2 Men Face Cleanser Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Men Face Cleanser Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Men Face Cleanser Capacity and Market Share by Region (2013-2018)
3.2 Global Men Face Cleanser Production and Market Share by Region (2013-2018)
3.3 Global Men Face Cleanser Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3080949-global-men-face-cleanser-market-research-report-2018

4 Global Men Face Cleanser Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Men Face Cleanser Consumption by Region (2013-2018)
4.2 North America Men Face Cleanser Production, Consumption, Export, Import (2013-2018)
4.3 Europe Men Face Cleanser Production, Consumption, Export, Import (2013-2018)
4.4 China Men Face Cleanser Production, Consumption, Export, Import (2013-2018)
4.5 Japan Men Face Cleanser Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Men Face Cleanser Production, Consumption, Export, Import (2013-2018)
4.7 India Men Face Cleanser Production, Consumption, Export, Import (2013-2018)

5 Global Men Face Cleanser Production, Revenue (Value), Price Trend by Type
5.1 Global Men Face Cleanser Production and Market Share by Type (2013-2018)
5.2 Global Men Face Cleanser Revenue and Market Share by Type (2013-2018)
5.3 Global Men Face Cleanser Price by Type (2013-2018)
5.4 Global Men Face Cleanser Production Growth by Type (2013-2018)

6 Global Men Face Cleanser Market Analysis by Application
6.1 Global Men Face Cleanser Consumption and Market Share by Application (2013-2018)
6.2 Global Men Face Cleanser Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Men Face Cleanser Manufacturers Profiles/Analysis
7.1 Loreal
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Men Face Cleanser Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Loreal Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 P&G
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Men Face Cleanser Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 P&G Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Unilever
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Men Face Cleanser Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Unilever Men Face Cleanser Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Estee Lauder
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Men Face Cleanser Product Category, Application and Specification

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/global-men-face-cleanser-market-industry-size-growth-analysis-and-forecast-of-2025/386595

For more information, please visit https://www.wiseguyreports.com/sample-request/3080949-global-men-face-cleanser-market-research-report-2018

Source: MarketersMedia

Release ID: 386595

Intelligent Greenhouse Market 2018 – Industry Analysis, Size, Share, Strategies and Forecast to 2025

New Study on “2018-2025 Intelligent Greenhouse Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Pune, India – July 31, 2018 /MarketersMedia/

Global Intelligent Greenhouse Industry

New Study on “2018-2025 Intelligent Greenhouse Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Intelligent Greenhouse market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Venlo
Palram
RBI
Kubo
Nexus Corporation
Agra Tech
Luiten
Atlas Manufacturing
AgrowTec
TOP Greenhouse
FatDragon
Fenglong Technology
Hua Kun
HuiZhong XingTong
Shangyang Greenhouse
Shanghai Jinong
Xinyu Greenhouse
NongBang Greenhouse
GaoZongZhi
Nanjing Tengyong
Jin Zhi You
Qingzhou Jinxin

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3089108-global-intelligent-greenhouse-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intelligent Greenhouse in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Hydroponic
Non-Hydroponic
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Flower Planting
Vegetable Cultivation
Fruit Cultivation
Other

Some points from table of content:

Global Intelligent Greenhouse Market Research Report 2018
1 Intelligent Greenhouse Market Overview
1.1 Product Overview and Scope of Intelligent Greenhouse
1.2 Intelligent Greenhouse Segment by Type (Product Category)
1.2.1 Global Intelligent Greenhouse Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Intelligent Greenhouse Production Market Share by Type (Product Category) in 2017
1.2.3 Hydroponic
1.2.4 Non-Hydroponic
1.3 Global Intelligent Greenhouse Segment by Application
1.3.1 Intelligent Greenhouse Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Flower Planting
1.3.3 Vegetable Cultivation
1.3.4 Fruit Cultivation
1.3.5 Other
1.4 Global Intelligent Greenhouse Market by Region (2013-2025)
1.4.1 Global Intelligent Greenhouse Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Intelligent Greenhouse (2013-2025)
1.5.1 Global Intelligent Greenhouse Revenue Status and Outlook (2013-2025)
1.5.2 Global Intelligent Greenhouse Capacity, Production Status and Outlook (2013-2025)

2 Global Intelligent Greenhouse Market Competition by Manufacturers
2.1 Global Intelligent Greenhouse Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Intelligent Greenhouse Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Intelligent Greenhouse Production and Share by Manufacturers (2013-2018)
2.2 Global Intelligent Greenhouse Revenue and Share by Manufacturers (2013-2018)
2.3 Global Intelligent Greenhouse Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Intelligent Greenhouse Manufacturing Base Distribution, Sales Area and Product Type
2.5 Intelligent Greenhouse Market Competitive Situation and Trends
2.5.1 Intelligent Greenhouse Market Concentration Rate
2.5.2 Intelligent Greenhouse Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Intelligent Greenhouse Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Intelligent Greenhouse Capacity and Market Share by Region (2013-2018)
3.2 Global Intelligent Greenhouse Production and Market Share by Region (2013-2018)
3.3 Global Intelligent Greenhouse Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3089108-global-intelligent-greenhouse-market-research-report-2018

4 Global Intelligent Greenhouse Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Intelligent Greenhouse Consumption by Region (2013-2018)
4.2 North America Intelligent Greenhouse Production, Consumption, Export, Import (2013-2018)
4.3 Europe Intelligent Greenhouse Production, Consumption, Export, Import (2013-2018)
4.4 China Intelligent Greenhouse Production, Consumption, Export, Import (2013-2018)
4.5 Japan Intelligent Greenhouse Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Intelligent Greenhouse Production, Consumption, Export, Import (2013-2018)
4.7 India Intelligent Greenhouse Production, Consumption, Export, Import (2013-2018)

5 Global Intelligent Greenhouse Production, Revenue (Value), Price Trend by Type
5.1 Global Intelligent Greenhouse Production and Market Share by Type (2013-2018)
5.2 Global Intelligent Greenhouse Revenue and Market Share by Type (2013-2018)
5.3 Global Intelligent Greenhouse Price by Type (2013-2018)
5.4 Global Intelligent Greenhouse Production Growth by Type (2013-2018)

6 Global Intelligent Greenhouse Market Analysis by Application
6.1 Global Intelligent Greenhouse Consumption and Market Share by Application (2013-2018)
6.2 Global Intelligent Greenhouse Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Intelligent Greenhouse Manufacturers Profiles/Analysis
7.1 Venlo
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Intelligent Greenhouse Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Venlo Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Palram
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Intelligent Greenhouse Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Palram Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 RBI
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Intelligent Greenhouse Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 RBI Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Kubo
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Intelligent Greenhouse Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Kubo Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Nexus Corporation
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Intelligent Greenhouse Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Nexus Corporation Intelligent Greenhouse Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/intelligent-greenhouse-market-2018-industry-analysis-size-share-strategies-and-forecast-to-2025/386592

For more information, please visit https://www.wiseguyreports.com/sample-request/3089108-global-intelligent-greenhouse-market-research-report-2018

Source: MarketersMedia

Release ID: 386592

Microsegmentation Market Segmentation, Parameters and Prospects 2018 to 2025 Market Research Report

New Study on “2018-2025 Microsegmentation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Pune, India – July 31, 2018 /MarketersMedia/

Global Microsegmentation Industry

New Study on “2018-2025 Microsegmentation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

This report studies the global Microsegmentation market, analyzes and researches the Microsegmentation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
VMware
Cisco
Unisys
Varmour
Opaq Networks
Nutanix
Cloudvisory
Guardicore
Extrahop
Shieldx Networks
Bracket Computing

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3089356-global-microsegmentation-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
Network Security
Database Security
Application Security

Market segment by Application, Microsegmentation can be split into
Small and Medium-sized Enterprises
Large Enterprises

Some points from table of content:

Global Microsegmentation Market Size, Status and Forecast 2025
1 Industry Overview of Microsegmentation
1.1 Microsegmentation Market Overview
1.1.1 Microsegmentation Product Scope
1.1.2 Market Status and Outlook
1.2 Global Microsegmentation Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Microsegmentation Market by Type
1.3.1 Network Security
1.3.2 Database Security
1.3.3 Application Security
1.4 Microsegmentation Market by End Users/Application
1.4.1 Small and Medium-sized Enterprises
1.4.2 Large Enterprises

2 Global Microsegmentation Competition Analysis by Players
2.1 Microsegmentation Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3089356-global-microsegmentation-market-size-status-and-forecast-2025

3 Company (Top Players) Profiles
3.1 VMware
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Cisco
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 Unisys
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Varmour
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Opaq Networks
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Nutanix
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Cloudvisory
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Guardicore
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments
3.9 Extrahop
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.9.5 Recent Developments
3.10 Shieldx Networks
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Microsegmentation Revenue (Million USD) (2013-2018)
3.10.5 Recent Developments
3.11 Bracket Computing

4 Global Microsegmentation Market Size by Type and Application (2013-2018)
4.1 Global Microsegmentation Market Size by Type (2013-2018)
4.2 Global Microsegmentation Market Size by Application (2013-2018)
4.3 Potential Application of Microsegmentation in Future
4.4 Top Consumer/End Users of Microsegmentation

5 United States Microsegmentation Development Status and Outlook
5.1 United States Microsegmentation Market Size (2013-2018)
5.2 United States Microsegmentation Market Size and Market Share by Players (2013-2018)
5.3 United States Microsegmentation Market Size by Application (2013-2018)

6 EU Microsegmentation Development Status and Outlook
6.1 EU Microsegmentation Market Size (2013-2018)
6.2 EU Microsegmentation Market Size and Market Share by Players (2013-2018)
6.3 EU Microsegmentation Market Size by Application (2013-2018)

7 Japan Microsegmentation Development Status and Outlook
7.1 Japan Microsegmentation Market Size (2013-2018)
7.2 Japan Microsegmentation Market Size and Market Share by Players (2013-2018)
7.3 Japan Microsegmentation Market Size by Application (2013-2018)

Continued…….

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/microsegmentation-market-segmentation-parameters-and-prospects-2018-to-2025-market-research-report/386599

For more information, please visit https://www.wiseguyreports.com/sample-request/3089356-global-microsegmentation-market-size-status-and-forecast-2025

Source: MarketersMedia

Release ID: 386599

Global Activated Charcoal Supplement Market by Manufacturers, Types, Regions and Application Research Report Forecast to 2025

Global Activated Charcoal Supplement Market Research Report 2018 contains historic data that spans 2013 to 2017, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Industry

Pune, India – July 31, 2018 /MarketersMedia/

Global Activated Charcoal Supplement Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Activated Charcoal Supplement. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Activated Charcoal Supplement market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Activated Charcoal Supplement Market is headed.

Access complete report at: https://www.themarketreports.com/report/global-activated-charcoal-supplement-market-research-report-2018

With this Activated Charcoal Supplement Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Nature’s Way, Country Life, Holland & Barrett, Forza, Simplysupplements, Sona, Swanson Premium, Amy Myers, Bulletproof, Schizandu Organics, Shandong Rike Chemicals, Novista Group and others.

Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1227644

When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn’t shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Activated Charcoal Supplement Industry, per application.

All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1227644

List of Chapters:
1 Activated Charcoal Supplement Market Overview
2 Global Activated Charcoal Supplement Market Competitions by Manufacturers
3 Global Activated Charcoal Supplement Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Activated Charcoal Supplement Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Activated Charcoal Supplement Production, Revenue (Value), Price Trend by Type
6 Global Activated Charcoal Supplement Market Analysis by Application
7 Global Activated Charcoal Supplement Manufacturers Profiles/Analysis
8 Activated Charcoal Supplement Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Activated Charcoal Supplement Market Forecast (2018-2025)
13 Research Findings and Conclusion
14 Appendix

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/global-activated-charcoal-supplement-market-by-manufacturers-types-regions-and-application-research-report-forecast-to-2025/386604

For more information, please visit https://www.themarketreports.com/report/global-activated-charcoal-supplement-market-research-report-2018

Source: MarketersMedia

Release ID: 386604

Global Oat Bran Market Segmentation, Parameters and Prospects 2018 to 2025 Market Research Report

New Study on “2018-2025 Oat Bran Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Pune, India – July 31, 2018 /MarketersMedia/

Global Oat Bran Industry

New Study on “2018-2025 Oat Bran Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Oat Bran market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bob’s Red Mill
Mornflake
Richardson Milling
Quaker
Grocery & Gourmet Food
Hodgson Mill
Milanaise
Kellogg’s
Flahavans
Now Health Group
Ceres Organics
Bulk Barn Foods

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3078737-global-oat-bran-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oat Bran in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Organic Oat Bran
Normal Oat Bran
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Online Sales
Hypermarkets and Supermarkets
Convenience Stores
Food and Drink Specialty Stores
Others

Some points from table of content:

Global Oat Bran Market Research Report 2018
1 Oat Bran Market Overview
1.1 Product Overview and Scope of Oat Bran
1.2 Oat Bran Segment by Type (Product Category)
1.2.1 Global Oat Bran Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Oat Bran Production Market Share by Type (Product Category) in 2017
1.2.3 Organic Oat Bran
1.2.4 Normal Oat Bran
1.3 Global Oat Bran Segment by Application
1.3.1 Oat Bran Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Online Sales
1.3.3 Hypermarkets and Supermarkets
1.3.4 Convenience Stores
1.3.5 Food and Drink Specialty Stores
1.3.6 Others
1.4 Global Oat Bran Market by Region (2013-2025)
1.4.1 Global Oat Bran Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Oat Bran (2013-2025)
1.5.1 Global Oat Bran Revenue Status and Outlook (2013-2025)
1.5.2 Global Oat Bran Capacity, Production Status and Outlook (2013-2025)

2 Global Oat Bran Market Competition by Manufacturers
2.1 Global Oat Bran Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Oat Bran Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Oat Bran Production and Share by Manufacturers (2013-2018)
2.2 Global Oat Bran Revenue and Share by Manufacturers (2013-2018)
2.3 Global Oat Bran Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Oat Bran Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oat Bran Market Competitive Situation and Trends
2.5.1 Oat Bran Market Concentration Rate
2.5.2 Oat Bran Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Oat Bran Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Oat Bran Capacity and Market Share by Region (2013-2018)
3.2 Global Oat Bran Production and Market Share by Region (2013-2018)
3.3 Global Oat Bran Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3078737-global-oat-bran-market-research-report-2018

4 Global Oat Bran Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Oat Bran Consumption by Region (2013-2018)
4.2 North America Oat Bran Production, Consumption, Export, Import (2013-2018)
4.3 Europe Oat Bran Production, Consumption, Export, Import (2013-2018)
4.4 China Oat Bran Production, Consumption, Export, Import (2013-2018)
4.5 Japan Oat Bran Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Oat Bran Production, Consumption, Export, Import (2013-2018)
4.7 India Oat Bran Production, Consumption, Export, Import (2013-2018)

5 Global Oat Bran Production, Revenue (Value), Price Trend by Type
5.1 Global Oat Bran Production and Market Share by Type (2013-2018)
5.2 Global Oat Bran Revenue and Market Share by Type (2013-2018)
5.3 Global Oat Bran Price by Type (2013-2018)
5.4 Global Oat Bran Production Growth by Type (2013-2018)

6 Global Oat Bran Market Analysis by Application
6.1 Global Oat Bran Consumption and Market Share by Application (2013-2018)
6.2 Global Oat Bran Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Oat Bran Manufacturers Profiles/Analysis
7.1 Bob’s Red Mill
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Oat Bran Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bob’s Red Mill Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Mornflake
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Oat Bran Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Mornflake Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Richardson Milling
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Oat Bran Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Richardson Milling Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Quaker
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Oat Bran Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Quaker Oat Bran Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Grocery & Gourmet Food
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Oat Bran Product Category, Application and Specification

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/global-oat-bran-market-segmentation-parameters-and-prospects-2018-to-2025-market-research-report/386600

For more information, please visit https://www.wiseguyreports.com/sample-request/3078737-global-oat-bran-market-research-report-2018

Source: MarketersMedia

Release ID: 386600

Global Men Perfume Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts to 2025

New Study on “2018-2025 Men Perfume Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Pune, India – July 31, 2018 /MarketersMedia/

Global Men Perfume Industry

New Study on “2018-2025 Men Perfume Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Men Perfume market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Coty
Loreal
Estee Lauder
Interparfums
Shiseido
LVMH
Chanel
Amore Pacific
Elizabeth Arden
Salvatore Ferragamo
AVON
Puig
ICR Spa
Procter & Gamble
Jahwa
Saint Melin

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3080950-global-men-perfume-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Men Perfume in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Essence
Perfume
Eau de Toilette
Cologne
Aftershave
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Specialist Retailers
Factory Outlets
Internet Sales
Other

Some points from table of content:

Global Men Perfume Market Research Report 2018
1 Men Perfume Market Overview
1.1 Product Overview and Scope of Men Perfume
1.2 Men Perfume Segment by Type (Product Category)
1.2.1 Global Men Perfume Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Men Perfume Production Market Share by Type (Product Category) in 2017
1.2.3 Essence
1.2.4 Perfume
1.2.5 Eau de Toilette
1.2.6 Cologne
1.2.7 Aftershave
1.2.8 Other
1.3 Global Men Perfume Segment by Application
1.3.1 Men Perfume Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Specialist Retailers
1.3.3 Factory Outlets
1.3.4 Internet Sales
1.3.5 Other
1.4 Global Men Perfume Market by Region (2013-2025)
1.4.1 Global Men Perfume Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Men Perfume (2013-2025)
1.5.1 Global Men Perfume Revenue Status and Outlook (2013-2025)
1.5.2 Global Men Perfume Capacity, Production Status and Outlook (2013-2025)

2 Global Men Perfume Market Competition by Manufacturers
2.1 Global Men Perfume Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Men Perfume Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Men Perfume Production and Share by Manufacturers (2013-2018)
2.2 Global Men Perfume Revenue and Share by Manufacturers (2013-2018)
2.3 Global Men Perfume Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Men Perfume Manufacturing Base Distribution, Sales Area and Product Type
2.5 Men Perfume Market Competitive Situation and Trends
2.5.1 Men Perfume Market Concentration Rate
2.5.2 Men Perfume Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3080950-global-men-perfume-market-research-report-2018

3 Global Men Perfume Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Men Perfume Capacity and Market Share by Region (2013-2018)
3.2 Global Men Perfume Production and Market Share by Region (2013-2018)
3.3 Global Men Perfume Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Men Perfume Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Men Perfume Consumption by Region (2013-2018)
4.2 North America Men Perfume Production, Consumption, Export, Import (2013-2018)
4.3 Europe Men Perfume Production, Consumption, Export, Import (2013-2018)
4.4 China Men Perfume Production, Consumption, Export, Import (2013-2018)
4.5 Japan Men Perfume Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Men Perfume Production, Consumption, Export, Import (2013-2018)
4.7 India Men Perfume Production, Consumption, Export, Import (2013-2018)

5 Global Men Perfume Production, Revenue (Value), Price Trend by Type
5.1 Global Men Perfume Production and Market Share by Type (2013-2018)
5.2 Global Men Perfume Revenue and Market Share by Type (2013-2018)
5.3 Global Men Perfume Price by Type (2013-2018)
5.4 Global Men Perfume Production Growth by Type (2013-2018)

6 Global Men Perfume Market Analysis by Application
6.1 Global Men Perfume Consumption and Market Share by Application (2013-2018)
6.2 Global Men Perfume Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Men Perfume Manufacturers Profiles/Analysis
7.1 Coty
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Men Perfume Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Coty Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Loreal
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Men Perfume Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Loreal Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Estee Lauder
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Men Perfume Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Estee Lauder Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Interparfums
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Men Perfume Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Interparfums Men Perfume Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Shiseido
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Men Perfume Product Category, Application and Specification

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/global-men-perfume-market-analysis-2018-by-segment-key-players-and-applications-and-forecasts-to-2025/386596

For more information, please visit https://www.wiseguyreports.com/sample-request/3080950-global-men-perfume-market-research-report-2018

Source: MarketersMedia

Release ID: 386596

Operating Room Equipments Market Opportunity Protein Labeling by Key Players, Regional Segmentation and Forecasts, 2018 – 2025

New Study on “2018-2025 Operating Room Equipments Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Pune, India – July 31, 2018 /MarketersMedia/

Global Operating Room Equipments Industry

New Study on “2018-2025 Operating Room Equipments Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Operating Room Equipments market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
STERIS Corporation
Getinge Group
Stryker Corporation
GE Healthcare
Mizuho OSI
Hill-Rom Holdings
Dragerwerk
Philips Healthcare

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3079302-global-operating-room-equipments-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Operating Room Equipments in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anesthesia Machines
Multi-parameter Patient Monitors
Surgical Imaging Devices
Operating Tables
Operating Room Lights
Patient Monitors
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Ambulatory Surgical Centers
Others

Some points from table of content:

Global Operating Room Equipments Market Research Report 2018
1 Operating Room Equipments Market Overview
1.1 Product Overview and Scope of Operating Room Equipments
1.2 Operating Room Equipments Segment by Type (Product Category)
1.2.1 Global Operating Room Equipments Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Operating Room Equipments Production Market Share by Type (Product Category) in 2017
1.2.3 Anesthesia Machines
1.2.4 Multi-parameter Patient Monitors
1.2.5 Surgical Imaging Devices
1.2.6 Operating Tables
1.2.7 Operating Room Lights
1.2.8 Patient Monitors
1.3 Global Operating Room Equipments Segment by Application
1.3.1 Operating Room Equipments Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Operating Room Equipments Market by Region (2013-2025)
1.4.1 Global Operating Room Equipments Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Operating Room Equipments (2013-2025)
1.5.1 Global Operating Room Equipments Revenue Status and Outlook (2013-2025)
1.5.2 Global Operating Room Equipments Capacity, Production Status and Outlook (2013-2025)

2 Global Operating Room Equipments Market Competition by Manufacturers
2.1 Global Operating Room Equipments Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Operating Room Equipments Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Operating Room Equipments Production and Share by Manufacturers (2013-2018)
2.2 Global Operating Room Equipments Revenue and Share by Manufacturers (2013-2018)
2.3 Global Operating Room Equipments Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Operating Room Equipments Manufacturing Base Distribution, Sales Area and Product Type
2.5 Operating Room Equipments Market Competitive Situation and Trends
2.5.1 Operating Room Equipments Market Concentration Rate
2.5.2 Operating Room Equipments Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3079302-global-operating-room-equipments-market-research-report-2018

3 Global Operating Room Equipments Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Operating Room Equipments Capacity and Market Share by Region (2013-2018)
3.2 Global Operating Room Equipments Production and Market Share by Region (2013-2018)
3.3 Global Operating Room Equipments Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Operating Room Equipments Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Operating Room Equipments Consumption by Region (2013-2018)
4.2 North America Operating Room Equipments Production, Consumption, Export, Import (2013-2018)
4.3 Europe Operating Room Equipments Production, Consumption, Export, Import (2013-2018)
4.4 China Operating Room Equipments Production, Consumption, Export, Import (2013-2018)
4.5 Japan Operating Room Equipments Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Operating Room Equipments Production, Consumption, Export, Import (2013-2018)
4.7 India Operating Room Equipments Production, Consumption, Export, Import (2013-2018)

5 Global Operating Room Equipments Production, Revenue (Value), Price Trend by Type
5.1 Global Operating Room Equipments Production and Market Share by Type (2013-2018)
5.2 Global Operating Room Equipments Revenue and Market Share by Type (2013-2018)
5.3 Global Operating Room Equipments Price by Type (2013-2018)
5.4 Global Operating Room Equipments Production Growth by Type (2013-2018)

6 Global Operating Room Equipments Market Analysis by Application
6.1 Global Operating Room Equipments Consumption and Market Share by Application (2013-2018)
6.2 Global Operating Room Equipments Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Operating Room Equipments Manufacturers Profiles/Analysis
7.1 STERIS Corporation
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Operating Room Equipments Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 STERIS Corporation Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Getinge Group
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Operating Room Equipments Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Getinge Group Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Stryker Corporation
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Operating Room Equipments Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Stryker Corporation Operating Room Equipments Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 GE Healthcare
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/operating-room-equipments-market-opportunity-protein-labeling-by-key-players-regional-segmentation-and-forecasts-2018-2025/386601

For more information, please visit https://www.wiseguyreports.com/sample-request/3079302-global-operating-room-equipments-market-research-report-2018

Source: MarketersMedia

Release ID: 386601